Indian Innovation Systems and Emergence of Biopharmaceutical Sector: Issues and Prospects

Sachin Chaturvedi
RIS-DP # 124
JEL codes: 
The prospective entry of generic dominated Indian pharmaceutical sector in the ambit of new technologies is likely to give filip to emergence of strong biopharmaceutical sector.It is pertinent in this context to draw a policy roadmap which takes into account sectoral dynamics and draws upon regional and international linkages. An appropriate balance between national system of innovation (NSI) and sectoral system of innovation (SSI) would determine trajactory of growth of this sector.